+44 1300 500008Clinical & Experimental Cardiology : Citations & Metrics Report
Articles published in Clinical & Experimental Cardiology have been cited by esteemed scholars and scientists all around the world. Clinical & Experimental Cardiology has got h-index 14, which means every article in Clinical & Experimental Cardiology has got 14 average citations.
Following are the list of articles that have cited the articles published in Clinical & Experimental Cardiology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
60 | 111 | 60 | 56 | 72 | 27 | 53 | 76 | 88 | 61 | 72 | 136 | 96 | 61 | 13 |
Research, Review articles and Editorials |
6 | 9 | 6 | 24 | 42 | 20 | 39 | 53 | 59 | 39 | 52 | 99 | 75 | 38 | 9 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
44 | 102 | 54 | 32 | 30 | 7 | 14 | 23 | 29 | 22 | 21 | 37 | 21 | 23 | 4 |
Conference proceedings |
24 | 25 | 41 | 43 | 3 | 49 | 398 | 389 | 515 | 204 | 157 | 126 | 26 | 33 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
143 | 212 | 54 | 63 | 88 | 70 | 62 | 294 | 304 | 211 | 147 | 75 | 29 | 93 | 0 |
| Journal total citations count | 2980 |
| Journal impact factor | 1.05 |
| Journal 5 years impact factor | 1.27 |
| Journal cite score | 1.34 |
| Journal h-index | 14 |
| Journal h-index since 2019 | 9 |
Important citations (1711)
hou y, adrian-segarra jm, richter (2015) animal models and “omics” technologies for identification of novel biomarkers and drug targets to prevent heart failure. biomed research international. |
|
messa p (2014) fgf23 and vascular calcifications: another piece of the puzzle?. nephrology dialysis transplantation. 29: 1447-1449. |
|
richter m, lautze hj, walther (2015) the failing heart is a major source of circulating fgf23 via oncostatin m receptor activation. the journal of heart and lung transplantation. 34: 1211-1214. |
|
andersen ia, huntley bk, sandberg (2016) elevation of circulating but not myocardial fgf23 in human acute decompensated heart failure. nephrology dialysis transplantation. 31: 767-772 |
|
van venrooij na, pereira rc, (2014) fgf23 protein expression in coronary arteries is associated with impaired kidney function. nephrology dialysis transplantation. |
|
scialla jj, wolf m (2014) roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. nature reviews nephrology. 10: 268-278. |
|
parsons xh, inventor san diego (2016) technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells. united states patent us 9,428,731. |
|
parsons xh, inventor san diego (2014) technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells. united states patent application us 14/520,990. |
|
parsons xh (2016) journal of regenerative therapeutics volume 1, issue 1, october 2016, pages 1–8. journal of regenerative therapeutics. |
|
parsons xh, inventor san diego (2014) technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells. united states patent us 8,716,017. |
|
parsons xh (2016) human pluripotent stem cell-based plurixcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. j regen ther. |
|
parsons xh (2014) the openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. int j cancer ther oncol. |
|
parsons xh (2013) exploring future cardiovascular medicine: heart precursors directed from human embryonic stem cells for myocardium regeneration. cardiovascular pharmacology: open access. |
|
parsons xh (2013) cellular medicine for the heart-the pharmacologic utility and capacity of human cardiac stem cells. j clin exp cardiolog s. |
|
parsons xh (2013) reviving cell-based regenerative medicine for heart reconstitution with efficiency in deriving cardiac elements from pluripotent human embryonic stem cells. cardiovascular pharmacology: open access. |
|
parsons xh (2016) direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. human embryonic stem cell protocols :299-318. |
|
parsons xh (2012) mending the broken heart-towards clinical application of human embryonic stem cell therapy derivatives. j clin exp cardiolog. |
|
parsons xh (2013) constraining the pluripotent fate of human embryonic stem cells for tissue engineering and cell therapy–the turning point of cell-based regenerative medicine. british biotechnology journal 3: 424. |
|
parsons xh (2013) embedding the future of regenerative medicine into the open epigenomic landscape of pluripotent human embryonic stem cells. annual research & review in biology. |
|
parsons xh (2013) human stem cell derivatives retain more open epigenomic landscape when derived from pluripotent cells than from tissues. journal of regenerative medicine 1. |
|